Certara To Participate In Upcoming Investor Conferences

2025-09-02 04:31:21

(MENAFN- GlobeNewsWire - Nasdaq) RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:

Baird Global Healthcare Conference
Date and Time: Tuesday, September 9 at 10:15 a.m. ET

Morgan Stanley 23 ^rd Annual Global Healthcare Conference
Date and Time: Wednesday, September 10 at 12:20 p.m. ET

Live webcasts for each of the conferences will be available on Certara's investor relations website at and will be available for replay for at least 90 days thereafter.

About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.com.

Investor Relations Contact:
David Deuchler
Gilmartin Group
...

Media Contact:
Alyssa Horowitz
...

MENAFN02092025004107003653ID1110008574

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.